Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study
Conditions
Interventions
edoxaban tosylate
enoxaparin/unfractionated heparin
+1 more
Locations
34
United States
Dothan, Alabama, United States
Montgomery, Alabama, United States
Sacramento, California, United States
Atlantis, Florida, United States
Clearwater, Florida, United States
Fort Myers, Florida, United States
Start Date
August 1, 2012
Primary Completion Date
January 1, 2014
Completion Date
March 1, 2014
Last Updated
February 26, 2019
NCT07102160
NCT06519435
NCT06451003
NCT06480994
NCT05286710
NCT05476913
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions